LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: SAGE Publications
Languages: English
Types: Article
Subjects:
No abstract available.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Spadaccio C, Nappi F, Al-Attar N, et al. Old Myths, New Concerns: the LongTerm Efects of Ascending Aorta Replacement with Dacron Grafts. Not All hTat Glitters Is Gold. J Cardiovasc Transl Res. 2016;9(4):334-342.
    • 2. Nappi F, Spadaccio C, Fraldi M, et al. A composite semiresorbable armoured scafold stabilizes pulmonary autograft after the Ross operation: Mr Ross's dream fulfilled. J Thorac Cardiovasc Surg . 2016;151(1):155-164 e151.
    • 3. Spadaccio C, Montagnani S, Acar C, Nappi F. Introducing bioresorbable scaffolds into the show. A potential adjunct to resuscitate Ross procedure. Int J Cardiol. 2015;190:50-52.
    • 4. Rapetto F, Bruno VD, Guida G, Marsico R, Chivasso P, Zebele C. GentamicinImpregnated Collagen Sponge: Efectiveness in Preventing Sternal Wound Infection in High-Risk Cardiac Surgery. Drug Target Insights. 2016;10(Suppl 1): 9-13.
    • 5. Spadaccio C, Nappi F, De Marco F, et al. Preliminary In Vivo Evaluation of a Hybrid Armored Vascular Graft Combining Electrospinning and Additive Manufacturing Techniques. Drug Target Insights. 2016;10(Suppl 1):1-7.
    • 6. Spadaccio C, Chello M, Trombetta M, Rainer A, Toyoda Y, Genovese JA. Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med. 2009;13(3):422-439.
    • 7. Rainer A, Spadaccio C, Sedati P, et al. Electrospun hydroxyapatite-functionalized PLLA scafold: potential applications in sternal bone healing. Ann Biomed Eng. 2011;39(7):1882-1890.
    • 8. Spadaccio C, Rainer A, Centola M, et al. Heparin-releasing scafold for stem cells: a diferentiating device for vascular aims. Regen Med. 2010;5(4):645-657.
    • 9. Gaudino M, Cellini C, Pragliola C, et al. Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation. 2005;112(9 Suppl):I265-269.
    • 10. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352(21):2174-2183.
    • 11. Al-Attar N, Nataf P. Multiple extensive coronary artery stenting: does it compromise future surgical revascularization? Curr Opin Cardiol. 2007;22(6):529-533.
    • 12. Harrison DG. Endothelial dysfunction in the coronary microcirculation: a new clinical entity or an experimental finding? J Clin Invest. 1993;91(1):1-2.
    • 13. West NE, Qian H, Guzik TJ, et al. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: efects on vascular smooth muscle cell diferentiation and superoxide production. Circulation. 2001;104(13):1526-1532.
    • 14. Yang Z, Ruschitzka F, Rabelink TJ, et al. Diferent efects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure. Circulation. 1997;95(7): 1870-1876.
    • 15. Takamori N, Azuma H, Kato M, et al. High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention. Circulation. 2004;109(4):481-486.
    • 16. Tarr FI, Sasvari M, Tarr M, Racz R. Evidence of nitric oxide produced by the internal mammary artery graft in venous drainage of the recipient coronary artery. Ann Thorac Surg . 2005;80(5):1728-1731.
    • 17. Luscher TF, Diederich D, Siebenmann R, et al. Diference between endotheliumdependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med. 1988;319(8):462-467.
    • 18. Butterfield DA, Gu L, Di Domenico F, Robinson RA. Mass spectrometry and redox proteomics: applications in disease. Mass Spectrom Rev. 2014;33(4):277-301.
    • 19. Spadaccio C, Di Domenico F, Perluigi M, et al. Serum proteomics in patients with diagnosis of abdominal aortic aneurysm. Cardiovasc Pathol. 2012;21(4):283-290.
    • 20. Lyck Hansen M, Beck HC, Irmukhamedov A, Jensen PS, Olsen MH, Rasmussen LM. Proteome Analysis of Human Arterial Tissue Discloses Associations Between the Vascular Content of Small Leucine-Rich Repeat Proteoglycans and Pulse Wave Velocity. Arterioscler Thromb Vasc Biol . 2015;35(8):1896-1903.
    • 21. de la Cuesta F, Zubiri I, Maroto AS, et al. Deregulation of smooth muscle cell cytoskeleton within the human atherosclerotic coronary media layer. J Proteomics. 2013;82:155-165.
    • 22. de la Cuesta F, Alvarez-Llamas G, Maroto AS, et al. A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Mol Cell Proteomics. 2011;10(4):M110003517.
    • 23. de la Cuesta F, Barderas MG, Calvo E, et al. Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. J Proteomics. 2012;75(10):2960-2971.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article